miRNA-489-3p Improves Sepsis-Induced Lung Injury by Regulating Toll-Like Receptor 4 (TLR4) Signaling Pathway

被引:0
作者
He, Xiaowei [1 ]
Shao, Longgang [1 ]
Xu, Min [1 ]
Li, Tan [1 ]
Zheng, Namin [1 ]
Liu, Keqin [1 ]
机构
[1] Nanjing Univ Chinese Med, Emergency Dept, Affiliated Hosp 2, Nanjing 210019, Peoples R China
关键词
miRNA-489-3p; NR-8383; TLR4; MyD88; NF-kappa B(p65); DIFFERENTIATION; PROLIFERATION; EXPRESSION; MIR-125B; CANCER;
D O I
10.1166/jbt.2021.2562
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Aim: To discuss miRNA-489-3p in sepsis-induced lung injury. Materials and methods: Using NR-8383 as research cell in our study, and using LPS stimulation to sepsis induced lung injury vitro model. Measuring cell proliferation by MTS assay; using Elisa assay to measure IL-1 beta, IL-6 and TNF-alpha concentration; apoptosis cell number and apoptosis rate were evaluated using TUNEL and flow cytometry; gene and protein were measured by RT-PCR and WB assay; measuring p-NF-kappa B(p65) nuclear volume by Immunofluorescence (IF); using Luciferase reporter assay to analysis miRNA-489-3p and TLR4 correlation. Results: Cell proliferation rate significantly down-regulated (P<0.001), apoptosis cell number and apoptosis rate significantly increased (P < 0.001); IL-1 beta, IL-6 and TNF-alpha concentrations significantly up-regulated (P < 0.001); TLR4 and MyD88 gene and protein significantly increased (P < 0.001), NF-kappa B(p65) mRNA and p-NF-kappa B(p65) protein and nuclear volume significantly increased (P < 0.001). However, with miRNA-489-3p supplement, the cell proliferation rate, apoptosis cell number and apoptosis rate were significantly improved (P < 0.001, respectively) via TLR4, MyD88 and NF-kappa B(p65) mRNA and protein significantly depressing (P < 0.001, respectively). By LUC assay, miRNA-489-3p could target to TLR4 in NR-8383 cell. Conclusion: miRNA-489-3p overexpression had effect to improve sepsis induced lung injury via regulation TLR4/MyD88/NF-kappa B(p65).
引用
收藏
页码:1722 / 1729
页数:8
相关论文
共 50 条
[21]   PHLDA1 Promotes Lung Contusion by Regulating the Toll-Like Receptor 2 Signaling Pathway [J].
Wang, Shaohua ;
Zhang, Hua ;
Wang, An ;
Huang, Dayu ;
Fan, Jie ;
Lu, Lu ;
Chen, Xiaofeng .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 40 (05) :1198-1206
[22]   Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide as toll-like receptor 4 (TLR4) ligand and regulates TLR4 signalling [J].
Khuda, Imtiaz I-E. ;
Koide, Naoki ;
Noman, Abu S. M. ;
Dagvadorj, Jargalsaikhan ;
Tumurkhuu, Gantsetseg ;
Naiki, Yoshikazu ;
Komatsu, Takayuki ;
Yoshida, Tomoaki ;
Yokochi, Takashi .
IMMUNOLOGY, 2009, 128 (01) :e700-e706
[23]   Sequence variants of toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men [J].
Kim, Hae Jong ;
Bae, Joon Seol ;
Chang, In Ho ;
Kim, Kyung Do ;
Lee, Jaehyouk ;
Shin, Hyoung Doo ;
Lee, Ji Youl ;
Kim, Wun-Jae ;
Kim, Wonyong ;
Myung, Soon Chul .
WORLD JOURNAL OF UROLOGY, 2012, 30 (02) :225-232
[24]   Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis [J].
Smith, Rh. Ll. ;
Hebert, H. L. ;
Massey, J. ;
Bowes, J. ;
Marzo-Ortega, H. ;
Ho, P. ;
McHugh, N. J. ;
Worthington, J. ;
Barton, A. ;
Griffiths, C. E. M. ;
Warren, R. B. .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2016, 308 (03) :201-205
[25]   Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behcet's disease [J].
Boiardi, L. ;
Atzeni, F. ;
Casali, B. ;
Farnetti, E. ;
Nicoli, D. ;
Pipitone, N. ;
Catanoso, M. G. ;
Olivieri, I. ;
Cantini, F. ;
Salvi, F. ;
La Corte, R. ;
Triolo, G. ;
Filippini, D. ;
Paolazzi, G. ;
Salvarani, C. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (02) :S43-S47
[26]   Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways [J].
Xu, Changqing ;
Chen, Gang ;
Yang, Weiwei ;
Xu, Yizhe ;
Xu, Yongfang ;
Huang, Xuqing ;
Liu, Jiangang ;
Feng, Yuejuan ;
Xu, Yanchun ;
Liu, Baojun .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 28 (02) :1050-1058
[27]   Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease [J].
Budulac, Simona E. ;
Boezen, H. Marike ;
Hiemstra, Pieter S. ;
Lapperre, Therese S. ;
Vonk, Judith M. ;
Timens, Wim ;
Postma, Dirkje S. .
PLOS ONE, 2012, 7 (08)
[28]   Human lactoferrin activates NF-κB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling [J].
Ando, Ken ;
Hasegawa, Keiichi ;
Shindo, Ken-ichi ;
Furusawa, Tomoyasu ;
Fujino, Tomofumi ;
Kikugawa, Kiyomi ;
Nakano, Hiroyasu ;
Takeuchi, Osamu ;
Akira, Shizuo ;
Akiyama, Taishin ;
Gohda, Jin ;
Inoue, Jun-ichiro ;
Hayakawa, Makio .
FEBS JOURNAL, 2010, 277 (09) :2051-2066
[29]   The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers [J].
Lupi, Luiz Antonio ;
Cucielo, Maira Smaniotto ;
Silveira, Henrique Spaulonci ;
Gaiotte, Leticia Barbosa ;
Cesario, Roberta Carvalho ;
Ferreira Seiva, Fabio Rodrigues ;
de Almeida Chuffa, Luiz Gustavo .
LIFE SCIENCES, 2020, 247
[30]   Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway [J].
Shi, Min ;
Deng, Yilin ;
Yu, Heguo ;
Xu, Ling ;
Shi, Cuicui ;
Chen, Jiong ;
Li, Guangming ;
Du, Yiqi ;
Wang, Yu-gang .
MEDIATORS OF INFLAMMATION, 2019, 2019